UChicago Medicine adapts ambient AI for ED documentation to improve note accuracy and efficiency in emergency care settings.

Following the first Phase 3 study of HyBryte(TM) for the treatment of CTCL, the FDA and the EMA indicated that they would require a second successful Phase 3 trial to support mark ...

(NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, announced today that a patient ...

The infamous little blue pill that keeps men up and at ’em may improve a different kind of hardness — hardness of hearing, ...

With its European and Chinese partners, Kiwi drug minnow AFT Pharmaceuticals plans a 1000-patient trial of a novel iron ...

The best thrift stores feel like treasure troves, with equal parts bargain-bin finds, pre-loved designer investments, and ...

Study found drugs used to prevent shingles and treat erectile dysfunction could be promising for Alzheimer’s patients ...

A Co Fermanagh man with Stage 4 cancer was left lying on the floor of Altnagelvin Hospital for more than 50 hours. Ernie ...

A central Indiana toddler is currently fighting for his life at Cincinnati Children’s Hospital as he awaits a heart ...

In 2025 Pew asked Americans whether they are ldquo;concerned or excited about AI? rdquo; 50% chose lsquo;concerned, rsquo; 10% lsquo;excited .

We decode how stricter consent norms under DPDP will force brands, agencies and platforms to rebuild their data pipelines, personalisation models and programmatic workflows.

Around 3 in 2,000 people are born with hearing loss. Typically irreversible, it's a lifelong condition that often presents ...